Watkins Laura L

Show results for

Unknown (4)
Metabolomics (2)
Genomics (1)
Transcriptomics (1)

Organisms

Mus musculus (2)

Repository

biostudies-arrayexpress (2)
MetaboLights (2)

Technology Type

Mass spectrometry (2)

Instrument Platform

Q Exactive (2)

Publication Date

2015 (2)
2022 (2)

CHEBI ID

CHEBI:10033 (2)
CHEBI:131434 (2)
CHEBI:131982 (2)
CHEBI:131987 (2)
CHEBI:132188 (2)
CHEBI:132926 (2)
CHEBI:132948 (2)
CHEBI:132958 (2)
CHEBI:132966 (2)
CHEBI:132983 (2)
CHEBI:132994 (2)
CHEBI:133005 (2)
CHEBI:133026 (2)
CHEBI:133032 (2)
CHEBI:133046 (2)
CHEBI:133066 (2)
CHEBI:133077 (2)
CHEBI:133086 (2)
CHEBI:133089 (2)
CHEBI:133094 (2)
CHEBI:133096 (2)
CHEBI:133101 (2)
CHEBI:133112 (2)
CHEBI:133115 (2)
CHEBI:133119 (2)
CHEBI:133136 (2)
CHEBI:133139 (2)
CHEBI:133141 (2)
CHEBI:133144 (2)
CHEBI:133172 (2)

Metabolite Name

1,3,7-trimethylurate (2)
1,3-dimethylurate (2)
1,7-dimethylurate (2)
1-(1-enyl-palmitoyl)-GPE (P-16:0)* (2)
1-(1-enyl-stearoyl)-GPE (P-18:0)* (2)
1-arachidonoyl-GPA (20:4) (2)
1-arachidonoyl-GPI (20:4)* (2)
1-arachidoyl-GPC (20:0) (2)
1-dihomo-linoleoyl-GPC (20:2)* (2)
1-docosahexaenoyl-GPE (22:6)* (2)
1-docosapentaenoyl-GPC (22:5n3)* (2)
1-docosapentaenoyl-GPC (22:5n6)* (2)
1-eicosapentaenoyl-GPC (20:5)* (2)
1-eicosapentaenoyl-GPE (20:5)* (2)
1-eicosenoyl-GPC (20:1)* (2)
1-linolenoyl-GPC (18:3)* (2)
1-linoleoyl-GPC (18:2) (2)
1-linoleoyl-GPE (18:2)* (2)
1-linoleoyl-GPI (18:2)* (2)
1-margaroyl-2-linoleoyl-GPC (17:0/18:2)* (2)
1-margaroyl-GPC (17:0) (2)
1-methylhistidine (2)
1-methylnicotinamide (2)
1-methylurate (2)
1-methylxanthine (2)
1-myristoyl-2-palmitoyl-GPC (14:0/16:0) (2)
1-oleoyl-2-linoleoyl-GPC (18:1/18:2)* (2)
1-oleoyl-GPI (18:1)* (2)
1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* (2)
1-palmitoyl-2-arachidonoyl-GPI (16:0/20:4)* (2)

Study type

ChIP-seq (1)
Transcription profiling by array (1)

Release Date

2015 (2)
2023 (2)
2025 (1)
2022 (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Rare and common genetic determinants of metabolic individuality and their effects on human health (EPIC-Norfolk study assays)

Garrod’s concept of “chemical individuality” has contributed to comprehension of the molecular origins of human diseases. Untargeted high-throughput metabolomic technologies provide an in-depth snapshot of human metabolism at scale. We studied the genetic architecture of the human plasma metabolo...

2022-09-09 | MTBLS833 | MetaboLights

Rare and common genetic determinants of metabolic individuality and their effects on human health (INTERVAL study assays)

2022-09-09 | MTBLS834 | MetaboLights

Genomic Analysis Reveals Distinct Mechanisms and Functional Classes of SOX10-Regulated Genes in Melanocytes [ChIP-Seq]

We performed ChIP-Seq analysis of SOX10, histone H3 lysine 27 acetylation (H3K27ac) and H3K27 trimethylation (H3K27me3) in melanocytes to profile the genomic binding sites of SOX10 and the chromatin landscape. In parallel, we generated Sox10 haploinsufficient cell lines using gene knockout approache...

ORGANISM(S): Mus musculus

2015-07-03 | E-GEOD-69949 | biostudies-arrayexpress

Genomic Analysis Reveals Distinct Mechanisms and Functional Classes of SOX10-Regulated Genes in Melanocytes [gene expression]

ORGANISM(S): Mus musculus

2015-07-03 | E-GEOD-69860 | biostudies-arrayexpress

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.

Not available

S-EPMC9333998 | biostudies-literature

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.

Not available

S-EPMC11872607 | biostudies-literature

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.